News

LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland London, 28 April 2025- LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and the ...
Immunic's lead asset, vidofludimus calcium, shows promise in MS trials, with positive interim results. See why I rate IMUX ...
While technology may continue to be an excellent investment and repeat its outstanding returns of the past five years, the recent short-term sell-off flags the possibility of a significant slump and ...
German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech firm SpringWorks ...
CCRCs are helping Healthpeak Properties offset “weakness” in the laboratory segment of its portfolio, President and CEO Scott ...
Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...
The ADAM contraceptive is a hydrogel injected into the male sperm ducts to block the passage of sperm, and it seems to still ...
Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...
About seven months ago, a dividend investor shared his monthly dividend income details and portfolio on r/Dividends — a ...
As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...
Rossari Biotech Ltd ( ($IN:ROSSARI) ) just unveiled an update. Rossari Biotech Limited has released its earnings presentation for the fourth ...
With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...